BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang C, Iovanna J, Santofimia-Castaño P. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. Int J Mol Sci 2021;22:4970. [PMID: 34067040 DOI: 10.3390/ijms22094970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Barret M, Doridot L, Le Gall M, Beuvon F, Jacques S, Pellat A, Belle A, Abou Ali E, Dhooge M, Leblanc S, Camus M, Nicco C, Coriat R, Chaussade S, Batteux F, Prat F. Mechanisms of esophageal stricture after extensive endoscopic resection: a transcriptomic analysis. Endosc Int Open 2023;11:E149-56. [PMID: 36741340 DOI: 10.1055/a-2000-8801] [Reference Citation Analysis]
2 Enderes J, Pillny C, Matthaei H, Manekeller S, Kalff JC, Glowka TR. Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: How We Do It. Biology (Basel) 2023;12. [PMID: 36829457 DOI: 10.3390/biology12020178] [Reference Citation Analysis]
3 Wang Y, Zhang Y, Wang Z, Yu L, Chen K, Xie Y, Liu Y, Liang W, Zheng Y, Zhan Y, Ding Y. The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis. Cell Death Discov 2022;8:431. [DOI: 10.1038/s41420-022-01213-z] [Reference Citation Analysis]
4 Yu X, Zhang Q, Zhang S, He Y, Guo W. Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients. Front Oncol 2022;12:1000447. [DOI: 10.3389/fonc.2022.1000447] [Reference Citation Analysis]
5 Cercillieux A, Ratajczak J, Joffraud M, Sanchez-Garcia JL, Jacot G, Zollinger A, Métairon S, Giroud-Gerbetant J, Rumpler M, Ciarlo E, Valera-Alberni M, Sambeat A, Canto C. Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure. Mol Metab 2022;66:101605. [PMID: 36165811 DOI: 10.1016/j.molmet.2022.101605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fukui H, Onishi H, Nakamoto A, Tsuboyama T, Ota T, Yano K, Enchi Y, Yamada D, Takeda Y, Kobayashi S, Fukuda Y, Eguchi H, Matsui T, Tatsumi M, Tomiyama N. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer. Eur J Radiol 2022;156:110522. [PMID: 36113381 DOI: 10.1016/j.ejrad.2022.110522] [Reference Citation Analysis]
7 Peng G, Tang X, Gui Y, Yang J, Ye L, Wu L, Ding YH, Wang L. Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases. Front Physiol 2022;13:951980. [DOI: 10.3389/fphys.2022.951980] [Reference Citation Analysis]
8 McCubrey JA, Yang LV, Abrams SL, Steelman LS, Follo MY, Cocco L, Ratti S, Martelli AM, Augello G, Cervello M. Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression. Cells 2022;11:2155. [PMID: 35883598 DOI: 10.3390/cells11142155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]